Vitamin B1 (Thiamine): No Known UL (Safe at High Doses)

Thiamine has no established UL (FDA DRI) and toxicity from typical intakes is uncommon. That does not justify unlimited megadosing: any stack should be rational, especially if you duplicate thiamine across energy blends, multivitamins, and metabolism complexes. Alcohol misuse increases thiamine depletion risk. Thiamine lacks a defined UL largely because typical supplemental ranges are well tolerated, yet alcohol-related depletion and malabsorption scenarios turn thiamine into an urgent clinical repletion topic rather than a retail stacking contest. Duplicate thiamine across multis and “metabolism” blends still adds pointless pill burden. Treat each bottle as a line item with dose, frequency, and ingredient form—not only a brand name. NutriAudit normalizes units, flags duplicate nutrient paths across products, and surfaces totals that approach tolerable upper intake levels from authoritative references. Use the export as a conversation starter with your clinician before surgery, pregnancy, new prescriptions, or whenever symptoms shift alongside product changes. Retail marketing and percent daily value lines do not replace summing the same vitamin or mineral across every source you actually take in a day. Proprietary blends still leave you responsible for recognizable vitamins and minerals underneath; photograph both the marketing panel and the Supplement Facts table when you open a new bottle so later dose reconstruction does not depend on memory alone. Supplement facts panels round numbers and sometimes list proprietary blends without gram-for-gram transparency for every ingredient. That opacity matters less for trace novelty compounds and more for nutrients with defined ULs, where small per-serving amounts still become dangerous when four products share the same category. Serving size tricks also distort perception: “two tablets daily” doubles the printed per-tablet dose, and powders measured with unpacked scoops vary wildly. International units for vitamins A, D, and E require conversion before you can compare totals to milligram or microgram UL tables. If you travel or import products, label conventions differ; relying on percent daily value alone is risky because DV targets are not identical to UL ceilings. A disciplined audit writes down each product, dose, and frequency, then converts units once. Kidney disease shifts the safety curve for magnesium, potassium, vitamin D metabolites, and some protein-adjacent supplement categories. Liver disease changes retinoid storage, clotting factor production, and detoxification capacity for concentrated herbal extracts. Malabsorption syndromes, bariatric anatomy, celiac disease, and inflammatory bowel flares change which forms and doses are appropriate even when a generic blog recommends a “standard” amount. Athletes may have higher turnover for some nutrients yet still face iron misadventure if they stack multiple iron paths without ferritin monitoring. None of these contexts are solved by buying a more expensive brand; they require individualized medical planning with periodic labs when indicated. Label percent daily value is a teaching tool aligned to population reference intakes, not a toxicity meter. You can be below 100% DV on every bottle yet exceed a UL when four bottles each carry 50–80% of the same nutrient. Conversely, B12 labels showing thousands of percent DV reflect absorption science, not a mandate to stack five B12 products. “Natural,” “clean,” and “pharmaceutical grade” are marketing phrases without standardized regulatory definitions for safety. Third-party testing certifications help quality-minded buyers but do not replace arithmetic on totals. If marketing claims cite a single study, ask whether that study used the same population, dose, and duration as your stack. FDA Dietary Reference Intakes publish Recommended Dietary Allowances and Tolerable Upper Intake Levels so consumers and clinicians can compare habitual intake to evidence-based safety envelopes. Those numbers assume you add every relevant source in a day: tablets, capsules, powders, functional beverages, and sometimes fortified foods that repeat the same nutrient under unfamiliar names. When two products both say “immune support” but one lists ascorbic acid and another lists mineral ascorbates, your audit still has to treat them as the same vitamin C ledger entry. The same aggregation rule applies to retinol esters, multiple forms of magnesium salts, and duplicate B vitamins across energy products. NutriAudit’s overlap engine is designed to mirror that regulatory mindset: totals first, brand stories second. If your summed intake approaches or exceeds a UL, the next step is clinician review, not another retail product to “balance” the stack without labs. Travel jet lag prompts melatonin experiments; altitude and heat change hydration and sodium needs; alcohol-heavy trips stress thiamine context. “Immunity weeks” before travel often stack vitamin C, zinc lozenges, elderberry, and multis simultaneously. Training camps for athletes layer creatine, caffeine, beta-alanine, electrolytes, and protein until stimulant load and GI distress dominate recovery. None of these are forbidden; they require honest totals and sleep hygiene basics that supplements cannot replace. If you compete under anti-doping rules, batch-tested products matter more than trendy pre-workout branding. NutriAudit encourages you to export a single stack summary for clinicians whenever totals approach reference limits or when new symptoms coincide with product changes. Revisit the audit after hospital discharge, a course of antibiotics, intentional weight loss, or any sustained diet pattern shift that changes what you eat every day.